Correlation Between Design Therapeutics and 191216CX6

Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and 191216CX6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and 191216CX6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Design Therapeutics and COCA COLA CO, you can compare the effects of market volatilities on Design Therapeutics and 191216CX6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of 191216CX6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and 191216CX6.

Diversification Opportunities for Design Therapeutics and 191216CX6

-0.46

Correlation Coefficient

Design Therapeutics  191216CX6

Very good diversification

The 3 months correlation between Design and 191216CX6 is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and COCA COLA CO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COCA A CO and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with 191216CX6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COCA A CO has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and 191216CX6 go up and down completely randomly.

Pair Corralation between Design Therapeutics and 191216CX6

Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the 191216CX6. In addition to that, Design Therapeutics is 4.44 times more volatile than COCA COLA CO. It trades about -0.05 of its total potential returns per unit of risk. COCA COLA CO is currently generating about -0.06 per unit of volatility. If you would invest  6,085  in COCA COLA CO on December 25, 2024 and sell it today you would lose (293.00) from holding COCA COLA CO or give up 4.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	96.61%
Values	Daily Returns

Design Therapeutics  vs.  COCA COLA CO

Design Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Design Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

COCA A CO

Risk-Adjusted Performance

Very Weak

Over the last 90 days COCA COLA CO has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 191216CX6 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Design Therapeutics and 191216CX6

The main advantage of trading using opposite Design Therapeutics and 191216CX6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, 191216CX6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 191216CX6 will offset losses from the drop in 191216CX6's long position.

The idea behind Design Therapeutics and COCA COLA CO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.